THINK Surgical® Receives FDA Clearance of Second-Generation Active Robot

THINK Surgical announced that the Food and Drug Administration (FDA) has cleared the second-generation of the TSolution One Total Knee Application.  The system features an active robot for total knee replacement, providing fully automated bone preparation, and gives surgeons a choice of implant options. The new system features upgrades to the current system, including an enhanced pre-surgical planning user interface, quick-change tooling, improved surgeon accessories, and advanced bone model generation.  The clearance of the second-generation TSolution One Total Knee Application comes approximately one year after THINK's first-generation active robot was cleared.

Jay Yang, acting CEO, THINK Surgical Commented "The ongoing evolution of the TSolution One Total Knee Application is a testament to THINK Surgical's dedication and investment in advancing the use of robot technology in the orthopedic setting, The versatile, open platform provides surgeons with the flexibility of using a variety of implants, while offering hospitals and ambulatory surgery centers a sustainable, high throughput system for their ever-increasing total knee replacement procedures."

The TSolution One total Knee Application is comprised of TPLAN®, the 3D pre-surgical planning workstation, and TCAT®, the active robot that helps the surgeon execute each patient's individual preoperative plan with consistent results through fully automated bone preparation. This second-generation robot incorporates several changes to the hardware and software, which significantly enhance the system's efficiency, flexibility and ease of use while maintaining the precision and innovation that is the hallmark of the TSolution One Total Knee Application system.

Related Posts

Subscribe Our Newsletter